Quarterly report pursuant to Section 13 or 15(d)

Net loss per share (Details) - Schedule of outstanding shares of potentially dilutive securities were excluded from the computation of diluted net loss per share

v3.23.1
Net loss per share (Details) - Schedule of outstanding shares of potentially dilutive securities were excluded from the computation of diluted net loss per share - shares
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Schedule Of Outstanding Shares Of Potentially Dilutive Securities Were Excluded From The Computation Of Diluted Net Loss Per Share Abstract    
Options to purchase common stock 1,336,489 1,187,085
Warrants to purchase common stock 4,784,193 4,784,193
Contingently issuable warrants to purchase convertible preferred stock 157,000,888
Total 163,121,570 5,971,278